144 related articles for article (PubMed ID: 12376300)
1. Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
Gao L; Bai L; Nan QZ; Yang XS; Chen K; Wen HP; Lai ZS; Bo L; Zhang YL; Zhang ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):641-3. PubMed ID: 12376300
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
[TBL] [Abstract][Full Text] [Related]
4. [Estimation and clinical significance of serum soluble tumor necrosis factor receptors in patients with acute leukemia].
Lin M; Meng X
Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):245-8. PubMed ID: 11601213
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
Itoh Y; Okanoue T; Ohnishi N; Sakamoto M; Nishioji K; Nakagawa Y; Minami M; Murakami Y; Kashima K
Am J Gastroenterol; 1999 May; 94(5):1332-40. PubMed ID: 10235215
[TBL] [Abstract][Full Text] [Related]
6. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis.
Shimizu Y; Minemura M; Tsukishiro T; Kashii Y; Miyamoto M; Nishimori H; Higuchi K; Watanabe A
Hepatology; 1995 Aug; 22(2):525-31. PubMed ID: 7543436
[TBL] [Abstract][Full Text] [Related]
7. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of tumor necrosis factor (TNF), soluble receptors for TNF (55- and 75-kDa sTNFr), and soluble CD14 (sCD14) in epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Gagetti O; Prontera C; Bianchi R; Facchini V
Gynecol Oncol; 1995 Aug; 58(2):184-8. PubMed ID: 7542621
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis of ascitic fluid in patients with liver cirrhosis and hepatocellular carcinoma].
Takezaki E; Murakami S; Nishibayashi H; Kagawa K; Ohmori H
Gan No Rinsho; 1990 Nov; 36(14):2415-9. PubMed ID: 1979086
[TBL] [Abstract][Full Text] [Related]
11. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
[TBL] [Abstract][Full Text] [Related]
12. [Expression of tumor necrosis factor receptor on peripheral blood mononuclear cells from patients with primary hepatocellular carcinoma and effects of treatment on the expression].
Bai L; Huang CW; Gao L; Jiang B; Nan QZ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1099-100. PubMed ID: 12480583
[TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of serum soluble tumor necrosis factor receptor-I in patients with head and neck neoplasm].
Dong W; Xu J; Qiao Z; Wang N; Yu R
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):468-70. PubMed ID: 12761967
[TBL] [Abstract][Full Text] [Related]
14. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
15. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
Tur-Kaspa I; Maor Y; Weissenberg R; Madgar I; Aderka D; Dor J; Mashiach S; Wallach D
J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
[TBL] [Abstract][Full Text] [Related]
16. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Zhao J; Hu J; Cai J; Yang X; Yang Z
Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
[TBL] [Abstract][Full Text] [Related]
18. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis.
Sawabe Y; Iida S; Tabata Y; Yonemitsu H
Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
20. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
Zhou J; Zhao Q; Yao H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
